Kaiser Permanente, Walnut Creek Medical Center

Walnut Creek, California 94596

7 studies enrolling now · 12 studies all time

What they study most

Advanced Solid Tumors, Antibiotic Stewardship, Atrial Fibrillation and Flutter, Attention Deficit Disorder With Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia, Cutaneous Melanoma, Stage II, Heart Failure, Hemophilia A, Lymphoma, Non-Hodgkin

Studies at this site

• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting — Recruiting now
• Vancomycin Reduction Practices (VRP) in the NICU — Recruiting now
• Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
• Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib — Running, not enrolling
• Improving Risk Stratification of Emergency Department Patients With Acute Heart Failure — Enrolling by invitation
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Study of a Gene Therapy Treatment for Hemophilia A — Withdrawn before enrolling
• Clinical Decision Support for Atrial Fibrillation and Flutter — Status unconfirmed
• Effectiveness of the Quotient® ADHD Assessment in a System of Care — Stopped early